Når det kliniske resultat for den enkelte patient er opnået, skal dosis reduceres med 25 til 50% for at te
Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced by 25 to 50% in order to ensure that the lowest approved dose of Nespo is used to maintain lp